Non-Small Cell Lung Cancer
Report summarizes non-small cell lung cancer study findings from H. Kunitoh and co-researchers
Published in Clinical Trials Week, October 13th, 2008
"Preoperative chemotherapy is a promising strategy in patients with early-stage resectable non-small-cell lung cancer (NSCLC); optimal chemotherapy remains unclear. Clinical (c-) stage IB/II NSCLC patients were randomised to receive either two cycles of docetaxel (D)-cisplatin (P) combination chemotherapy (D 60 mg m(-2) and P 80 mg m(-2) on day 1) every 3-4 weeks or three cycles of D monotherapy (70 mg m(-2)) every 3 weeks," investigators in Tsukiji, Japan report.
"Thoracotomy was performed 4-5 weeks (DP) or 3-4 weeks (D) after chemotherapy. The primary end point was 1-year disease-free survival (DFS). From October 2002 to November 2003, 80 patients were randomised....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2008-10-13)
More Articles from Clinical Trials Week
- New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
HIV drug maraviroc effective for drug-resistant patients - Sciele Pharma, Inc.
Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature Ejaculation - Cancer
Research from Royal Marsden Hospital yields new findings on cancer - Cancer Vaccines
Reports from Stanford University describe recent advances in cancer vaccines - Carcinoma
New research on carcinoma from T. Andre and co-authors summarized - Chemotherapy
New findings from L.J. Swinnen and co-authors describe advances in chemotherapy - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
